Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti‐cancer effects and pharmacological properties von Hegedűs, C, Özvegy‐Laczka, C, Apáti, Á, Magócsi, M, Német, K, Őrfi, L, Kéri, G, Katona, M, Takáts, Z, Váradi, A, Szakács, G, Sarkadi, B

Volltext

CDK9 inhibition as an effective therapy for small cell lung cancer von Valdez Capuccino, L., Kleitke, T., Szokol, B., Svajda, L., Martin, F., Bonechi, F., Krekó, M., Azami, S., Montinaro, A., Wang, Y., Nikolov, V., Kaiser, L., Bonasera, D., Saggau, J., Scholz, T., Schmitt, A., Beleggia, F., Reinhardt, H. C., George, J., Liccardi, G., Walczak, H., Tóvári, J., Brägelmann, J., Montero, J., Sos, M. L., Őrfi, L., Peltzer, N.

Volltext

Novel members of quinoline compound family enhance insulin secretion in RIN-5AH beta cells and in rat pancreatic islet microtissue von Orfi, Z., Waczek, F., Baska, F., Szabadkai, I., Torka, R., Hartmann, J., Orfi, L., Ullrich, A.

Volltext

791: Investigation of the mode of action of sunitinib kinase inhibitor profile analogues in insulin release von Orfi, Z, Falcenberg, M, Eros, D, Orfi, L, Keri, G, Ullrich, A

Volltext

801: Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors − suggestion of combination therapy von Torka, R, Pénzes, K, Baumann, C, Gusenbauer, S, Szabadkai, I, Orfi, L, Kéri, G, Ullrich, A

Volltext

The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitors von Hutterer, C., Hamilton, S., Steingruber, M., Zeitträger, I., Bahsi, H., Thuma, N., Naing, Z., Örfi, Z., Örfi, L., Socher, E., Sticht, H., Rawlinson, W., Chou, S., Haupt, V.J., Marschall, M.

Volltext

Machine learning and docking models for Mycobacterium tuberculosis topoisomerase I von Ekins, Sean, Godbole, Adwait Anand, Kéri, György, Orfi, Lászlo, Pato, János, Bhat, Rajeshwari Subray, Verma, Rinkee, Bradley, Erin K, Nagaraja, Valakunja

Volltext

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers von Győrffy, Balázs, Bottai, Giulia, Lehmann-Che, Jacqueline, Kéri, György, Őrfi, László, Iwamoto, Takayuki, Desmedt, Christine, Bianchini, Giampaolo, Turner, Nicholas C., de Thè, Hugues, André, Fabrice, Sotiriou, Christos, Hortobagyi, Gabriel N., Di Leo, Angelo, Pusztai, Lajos, Santarpia, Libero

Volltext

High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter von Csilla Özvegy-Laczka, Tamás Hegedűs, György Várady, Olga Ujhelly, John D. Schuetz, András Váradi, György Kéri, László Őrfi, Katalin Német, Balázs Sarkadi

Volltext

Targeting of the VEGF-kinase inhibitor PTK787 to angiogenic vasculature using RGD-equipped albumin carrier molecules von Temming, K., Lacombe, M., Moorlag, H.E., Asgeirsdottir, S.A., Orfi, L., Kéri, G., Poelstra, K., Molema, G., Kok, R.J.

Volltext

Comparison of measured and calculated lipophilicity of substituted aurones and related compounds von Hallgas, B, Patonay, T, Kiss-Szikszai, A, Dobos, Zs, Hollósy, F, Erős, D, Őrfi, L, Kéri, Gy, Idei, M

Volltext

Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling von GODL, Klaus, GRUSS, Oliver J, KERI, György, MÜLLER, Stefan, COTTON, Matt, ULLRICH, Axel, DAUB, Henrik, EICKHOFF, Jan, WISSING, Josef, BLENCKE, Stephanie, WEBER, Martina, DEGEN, Heidrun, BREHMER, Dirk, ÖRFI, Laszlo, HORVATH, Zoltan

Volltext

Regulation of influenza a virus mRNA splicing by CLK1 von Artarini, A, Meyer, M, Shin, YJ, Huber, K, Hilz, N, Bracher, F, Eros, D, Orfi, L, Keri, G, Goedert, S, Neuenschwander, M, Von Kries, J, Domovich-Eisenberg, Y, Dekel, N, Szabadkai, I, Lebendiker, M, Horváth, Z, Danieli, T, Livnah, O, Moncorgé, O, Frise, R, Barclay, W, Meyer, TF, Karlas, A

Volltext

Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1 von Hegedűs, Tamás, Őrfi, László, Seprődi, Attila, Váradi, András, Sarkadi, Balázs, Kéri, György

Volltext

Characterization of binding mode of imatinib to human α1-acid glycoprotein von Fitos, I., Simon, Á., Zsila, F., Mády, G., Bencsura, Á., Varga, Z., Őrfi, L., Kéri, G., Visy, J.

Volltext

Acid−Base Profiling of Imatinib (Gleevec) and Its Fragments von Szakács, Zoltán, Béni, Szabolcs, Varga, Zoltán, Örfi, László, Kéri, György, Noszál, Béla

Volltext

A novel drug discovery concept for tuberculosis: Inhibition of bacterial and host cell signalling von Székely, Rita, Wáczek, Frigyes, Szabadkai, István, Németh, Gábor, Hegymegi-Barakonyi, Bálint, Erős, Dániel, Szokol, Bálint, Pató, János, Hafenbradl, Doris, Satchell, Jacqueline, Saint-Joanis, Brigitte, Cole, Stewart T, Őrfi, László, Klebl, Bert M, Kéri, György

Volltext

Delivery of the p38 MAPkinase Inhibitor SB202190 to Angiogenic Endothelial Cells:  Development of Novel RGD-Equipped and PEGylated Drug−Albumin Conjugates Using Platinum(II)-Based... von Temming, Kai, Lacombe, Marie, van der Hoeven, Paul, Prakash, Jai, Gonzalo, Teresa, Dijkers, Eli C. F, Orfi, László, Kéri, Gyorgy, Poelstra, Klaas, Molema, Grietje, Kok, Robbert J

Volltext

A Probabilistic Theory of Pattern Recognition von Devroye, Luc, Györfi, László, Lugosi, Gábor

Volltext

Sweet’s syndrome: Is the pathogenesis mediated by helper T cell type 1 cytokines? von Giasuddin, Abu S.M., El-Orfi, Abdul Hamed A.M., Ziu, Mustafa M., El-Barnawi, Naeema Y.

Volltext